醛固酮
原发性醛固酮增多症
肌酐
化学
尿
泌尿系统
内分泌学
内科学
色谱法
泌尿科
医学
作者
Nora Vogg,Lydia Kürzinger,Sabine Kendl,Christina Pamporaki,Graeme Eisenhofer,Christian Adolf,Stefanie Hahner,Martin Faßnacht,Max Kurlbaum
标识
DOI:10.1515/cclm-2023-0250
摘要
Abstract Objectives Primary aldosteronism is the most common cause of endocrine hypertension and is associated with significant cardiovascular morbidities. The diagnostic workup depends on determinations of plasma aldosterone and renin which are highly variable and associated with false-positive and false-negative results. Quantification of aldosterone in 24 h urine may provide more reliable results, but the methodology is not well established. We aimed to establish an assay for urinary aldosterone and related steroids with suitability for clinical routine implementation. Methods Here, we report on the development and validation of a quantitative LC-MS/MS method for six urinary steroids: aldosterone, cortisol, 18-hydroxycorticosterone, 18-hydroxycortisol, 18-oxocortisol, tetrahydroaldosterone. After enzymatic deconjugation, total steroids were extracted using SepPak tC18 plates and quantified in positive electrospray ionization mode on a QTRAP 6500+ mass spectrometer. Results Excellent linearity was demonstrated with R 2 >0.998 for all analytes. Extraction recoveries were 89.8–98.4 % and intra- and inter-day coefficients of variations were <6.4 and <9.0 %, establishing superb precision. Patients with primary aldosteronism (n=10) had higher mean 24 h excretions of aldosterone-related metabolites than normotensive volunteers (n=20): 3.91 (95 % CI 2.27–5.55) vs. 1.92 (1.16–2.68) µmol/mol for aldosterone/creatinine, 2.57 (1.49–3.66) vs. 0.79 (0.48–1.10) µmol/mol for 18-hydroxycorticosterone/creatinine, 37.4 (13.59–61.2) vs. 11.61 (10.24–12.98) µmol/mol for 18-hydroxycortisol/creatinine, 1.56 (0.34–2.78) vs. 0.13 (0.09–0.17) µmol/mol for 18-oxocortisol/creatinine, and 21.5 (13.4–29.6) vs. 7.21 (4.88–9.54) µmol/mol for tetrahydroaldosterone/creatinine. Conclusions The reported assay is robust and suitable for routine clinical use. First results in patient samples, though promising, require clinical validation in a larger sample set.
科研通智能强力驱动
Strongly Powered by AbleSci AI